Integrated single-cell RNA sequencing and two-sample Mendelian randomization reveal CD4 + T cell-expressed COMT and JUN as shared candidate genes for Alzheimer's disease and type 2 diabetes mellitus

Background Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are high-burden diseases; T2DM independently elevates AD risk via shared pathogenesis, yet their shared peripheral immune pathways and genetically supported cell-specific targets remain undefined. Objective To identify shared immune subsets, key genes and candidate compounds for AD and T2DM via integrated scRNA-seq and two-sample Mendelian randomization. Methods We constructed an integrated multi-omics framework combining peripheral blood mononuclear cell (PBMC) single-cell RNA sequencing (scRNA-seq) and two-sample Mendelian randomization (2SMR) using 10 public GEO datasets, with core analyses covering cell annotation, cell-cell communication profiling, differential expression analysis, eQTL-based 2SMR, in silico gene function prediction, and molecular docking with dynamics simulation for compound screening. Results CD4 + T cells were inferred as the most abundant adaptive immune subset and a potential intercellular communication hub in peripheral blood of both AD and T2DM. Dual scRNA-seq/2SMR screening identified consistently upregulated shared candidate genes COMT and JUN , validated at single-cell and bulk transcriptome levels; myricetin and tauroursodeoxycholic acid were screened as candidate compounds with high predicted binding affinity to the encoded proteins. The 100 ns molecular dynamics simulation confirmed favorable structural stability of the COMT -myricetin complex (RMSD ∼1.2 Å). Conclusions As an exploratory bioinformatics investigation, this study proposes a testable hypothesis that CD4 + T cells and the COMT / JUN axis may act as a potential shared immune regulatory node in the concurrent pathogenesis of AD and T2DM, differing from the canonical T cell-driven pathological process in classic autoimmune diseases. All findings remain preliminary and require dedicated experimental validation.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2026-11-14
DOI
https://doi.org/10.1177/13872877261506457
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated single-cell RNA sequencing and two-sample Mendelian randomization reveal CD4 + T cell-expressed COMT and JUN as shared candidate genes for Alzheimer's disease and type 2 diabetes mellitus

C.-Y. Ou, 于海东, Huajun Long, Jun Deng et al.
Journal of Alzheimer s Disease
Alzheimer's disease research and treatments
article

Integrated single-cell RNA sequencing and two-sample Mendelian randomization reveal CD4 + T cell-expressed COMT and JUN as shared candidate genes for Alzheimer's disease and type 2 diabetes mellitus

C.-Y. Ou, 于海东, Huajun Long, Jun Deng, Binbin Chen
article en

Abstract

Background Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are high-burden diseases; T2DM independently elevates AD risk via shared pathogenesis, yet their shared peripheral immune pathways and genetically supported cell-specific targets remain undefined. Objective To identify shared immune subsets, key genes and candidate compounds for AD and T2DM via integrated scRNA-seq and two-sample Mendelian randomization. Methods We constructed an integrated multi-omics framework combining peripheral blood mononuclear cell (PBMC) single-cell RNA sequencing (scRNA-seq) and two-sample Mendelian randomization (2SMR) using 10 public GEO datasets, with core analyses covering cell annotation, cell-cell communication profiling, differential expression analysis, eQTL-based 2SMR, in silico gene function prediction, and molecular docking with dynamics simulation for compound screening. Results CD4 + T cells were inferred as the most abundant adaptive immune subset and a potential intercellular communication hub in peripheral blood of both AD and T2DM. Dual scRNA-seq/2SMR screening identified consistently upregulated shared candidate genes COMT and JUN , validated at single-cell and bulk transcriptome levels; myricetin and tauroursodeoxycholic acid were screened as candidate compounds with high predicted binding affinity to the encoded proteins. The 100 ns molecular dynamics simulation confirmed favorable structural stability of the COMT -myricetin complex (RMSD ∼1.2 Å). Conclusions As an exploratory bioinformatics investigation, this study proposes a testable hypothesis that CD4 + T cells and the COMT / JUN axis may act as a potential shared immune regulatory node in the concurrent pathogenesis of AD and T2DM, differing from the canonical T cell-driven pathological process in classic autoimmune diseases. All findings remain preliminary and require dedicated experimental validation.

Journal of Alzheimer s Disease
Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine (The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine) (CN)
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon